ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine qualifies for phase II/III testing July 16, 2018 No Comments
Matinas collaborates with NINDS to develop HIV therapy based on LNC platform July 10, 2018 No Comments
Apabetalone reverses HIV-1 latency and induces apoptosis of reservoir cells June 12, 2018 No Comments
HIV-1 fusion peptide targeting, a promising vaccination strategy eliciting neutralizing antibodies June 12, 2018 No Comments
RSS